Naim Maalouf, M.D.
Associate Director, Director of the Charles and Jane Pak Center of Mineral Metabolism and Clinical Research
Endowed Title The Frederic C. Bartter Professorship in Vitamin D Research
Department Internal Medicine | Charles and Jane Pak Center for Mineral Metabolism and Clinical Research
You have reached the Academic Profile.
For more information on the doctor and patient care, please visit the clinical profile.View Clinical Profile
Naim Maalouf, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Endocrinology. He specializes in the medical evaluation and management of kidney stones, parathyroid disorders, osteoporosis, bone health in breast cancer, and other mineral metabolism disorders.
He is the Associate Director of The Charles and Jane Pak Center for Mineral Metabolism and Clinical Research at UTSW.
Dr. Maalouf earned his medical degree at American University of Beirut. He completed a residency in internal medicine at Emory University and received advanced training in endocrinology and metabolism through a fellowship at UT Southwestern.
Certified by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2004.
Dr. Maalouf is on the editorial board of Urolithiasis and is a member of several professional organizations, including the American Association of Clinical Endocrinologists, the American Society for Bone and Mineral Research, and the Endocrine Society.
He has been awarded several National Institutes of Health grants and is the principal investigator for the Urinary Stone Disease Research Network site at UT Southwestern. He has delivered scores of presentations and published numerous academic articles.
Among his many accolades, Dr. Maalouf earned the Jean D. Wilson Award for Excellence in Scientific Mentorship from the UT Southwestern Division of Endocrinology.
- Medical School
- American University of Beirut (1998)
- Emory University School of Medicine (2001), Internal Medicine
- UT Southwestern Medical Center (2004), Endocrinology & Metabolism
- Nephrolithiasis (Kidney Stone Disease)
- Parathyroid Disorders
- Uric Acid Nephrolithiasis
- Postmenopausal hormone use and the risk of nephrolithiasis: Results from the Women’s Health Initiative hormone therapy trials
- Maalouf NM, Sato AH, Welch BJ, Howard BV, Cochrane BB, Sakhaee K, Robbins JA. Archives of Internal Medicine October 2010 170 1678-1685
- Association of urinary pH with body weight in nephrolithiasis
- Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY Kidney Int April 2004 65 1422-1425
- Safety of bisphosphonates.
- Orozco C, Maalouf NM Rheum. Dis. Clin. North Am. 2012 Nov 38 4 681-705
- Hypercalciuria associated with high dietary protein intake is not due to acid load.
- Maalouf NM, Moe OW, Adams-Huet B, Sakhaee K J. Clin. Endocrinol. Metab. 2011 Dec 96 12 3733-40
- Metabolic basis for low urine pH in type 2 diabetes.
- Maalouf NM, Cameron MA, Moe OW, Sakhaee K. Clinical Journal of the American Society of Nephrology July 2010 5 1277-1281
- Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
- Maalouf NM, Tondapu P, Guth ES, Livingston EH, Sakhaee K. Journal of Urology March 2010 183 1026-1030
- The noncalciotropic actions of vitamin D: recent clinical developments
- Maalouf, NM Curr Opin Nephrol Hypertens July 2008 17 408-415
- Severely suppressed bone turnover: a potential complication of alendronate therapy.
- Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY J. Clin. Endocrinol. Metab. 2005 Mar 90 3 1294-301
Honors & Awards
- Alpha Omega Alpha
- American Association of Clinical Endocrinologists
- American Society for Bone and Mineral Research
- The Endocrine Society